Core Insights - Stereotaxis will showcase its surgical robotics technology at the HRX digital health conference from September 4-6, 2025, in Atlanta, Georgia, focusing on advancements in cardiovascular medicine [1] - CEO David Fischel will participate in a roundtable discussion and a panel session on innovative ablation techniques that leverage robotics and AI to enhance patient outcomes [2][3] Company Overview - Stereotaxis is a leader in surgical robotics for minimally invasive endovascular interventions, aiming to improve patient care through robotic precision and safety [4] - The company's technology has been utilized to treat over 150,000 patients globally, indicating a significant impact in the field of interventional cardiology [4]